Isha Pahuja
New Delhi, DL, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Carglumic acid and mesalazine as potential anti-mycobacterial agents: a spectroscopic study for repurposing drugs against Mycobacterium tuberculosis targeting its essential enzyme ThyX.
Journal: Microbiology spectrum
Published: October 13, 2025
Thymol as Biofilm and Efflux Pump Inhibitor: A Dual-Action Approach to Combat Mycobacterium tuberculosis.
Journal: Cell biochemistry and function
Published: October 07, 2024
Ajoene: a natural compound with enhanced antimycobacterial and antibiofilm properties mediated by efflux pump modulation and ROS generation against M. Smegmatis.
Journal: Archives of microbiology
Published: August 23, 2024
Bergenin potentiates BCG efficacy by enriching mycobacteria-specific adaptive memory responses via the Akt-Foxo-Stat4 axis.
Journal: Tuberculosis (Edinburgh, Scotland)
Published: March 13, 2024
Depletion of essential mycobacterial gene glmM reduces pathogen survival and induces host-protective immune responses against tuberculosis.
Journal: Communications biology
Published: September 18, 2023
Biapenem, a Carbapenem Antibiotic, Elicits Mycobacteria Specific Immune Responses and Reduces the Recurrence of Tuberculosis.
Journal: Microbiology spectrum
Published: June 05, 2023
Unravelling the potential of Triflusal as an anti-TB repurposed drug by targeting replication protein DciA.
Journal: Microbes and infection
Published: June 02, 2023
Atosiban and Rutin exhibit anti-mycobacterial activity - An integrated computational and biophysical insight toward drug repurposing strategy against Mycobacterium tuberculosis targeting its essential enzyme HemD.
Journal: International journal of biological macromolecules
Published: May 23, 2023
Adjunct Therapy With All-trans-Retinoic Acid Improves Therapeutic Efficacy Through Immunomodulation While Treating Tuberculosis With Antibiotics in Mice.
Journal: The Journal of infectious diseases
Published: May 08, 2023
Withaferin A Protects against Primary and Recurrent Tuberculosis by Modulating Mycobacterium-Specific Host Immune Responses.
Journal: Microbiology spectrum
Published: March 14, 2023
Cotreatment With Clofazimine and Rapamycin Eliminates Drug-Resistant Tuberculosis by Inducing Polyfunctional Central Memory T-Cell Responses.
Journal: The Journal of infectious diseases
Published: March 14, 2023
Last Updated: 09/26/2026